Literature DB >> 28299761

Comparison of Percutaneous Nephrolithotomy and Retrograde Intrarenal Surgery in Treating 20-40 mm Renal Stones.

Gokhan Atis1, Meftun Culpan2, Eyup Sabri Pelit3, Cengiz Canakci2, Ismail Ulus2, Bilal Gunaydin2, Asif Yildirim2, Turhan Caskurlu2.   

Abstract

PURPOSE: To compare the outcomes of percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS) in treating renal stones between 20 and 40 mm in diameter.
MATERIALS AND METHODS: 146 patients, who were treated with RIRS and 146 patients, who were treated with PCNL for renal stones between 20 and 40 mm in diameter were compared retrospectively using a matched-pair analysis. The operative and post-operative outcomes of both groups were analyzed retrospectively.
RESULTS: The mean age, gender, body mass index and stone laterality were similar between the groups. The mean stone size was 28.39 ± 4.67 mm for the PCNL group and 25.08 ± 6.07 mm for the RIRS group (P =.21). The mean operative times were statistically longer in the RIRS group, whereas the fluoroscopy times, hospitalization times and post-operative visual analogue scores were statistically higher in the PCNL group. The stone- free rates (SFR) after a single procedure were 91.7% in the PCNL group and 74% in the RIRS group (P = .04). After auxiliary procedures, the overall SFRs reached 94.4% for the PCNL group and 92.3% for the RIRS group (P = .52). No major complications were observed for both groups. Minor complication (Clavien 1-3) rates were 6.8% and 3.4% for the PCNL and RIRS group, respectively (P =.18).
CONCLUSION: RIRS has some advantages over PCNL such as shorter hospitalization times, shorter fluoroscopy times and less post-operative pain in treating renal stones between 20 and 40 mm in diameter. However, PCNL has a higher SFR with only a single session.

Entities:  

Mesh:

Year:  2017        PMID: 28299761

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  8 in total

1.  An easy risk stratification to recommend the optimal patients with 2-3 cm kidney stones to receive retrograde intrarenal surgery or mini-percutaneous nephrolithotomy.

Authors:  Zhijian Zhao; Hongling Sun; Tao Zeng; Tuo Deng; Yongda Liu; Guohua Zeng
Journal:  Urolithiasis       Date:  2019-05-17       Impact factor: 3.436

Review 2.  Miniaturisation of PCNL.

Authors:  Sven Lahme
Journal:  Urolithiasis       Date:  2017-12-14       Impact factor: 3.436

Review 3.  Research progress of percutaneous nephrolithotomy.

Authors:  Chao Wei; Yucong Zhang; Gaurab Pokhrel; Xiaming Liu; Jiahua Gan; Xiao Yu; Zhangqun Ye; Shaogang Wang
Journal:  Int Urol Nephrol       Date:  2018-03-19       Impact factor: 2.370

4.  Comparison of the Efficacy and Complications of Soft Ureteroscopy Lithotripsy and Percutaneous Nephrolithotomy in the Treatment of Urinary Calculi: A Systematic Review and Meta-analysis.

Authors:  WenLong Han; Jing Ge; Xianlin Xu
Journal:  Comput Math Methods Med       Date:  2022-07-01       Impact factor: 2.809

5.  Effectiveness of Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery, and Extracorporeal Shock Wave Lithotripsy for Treatment of Renal Stones: A Systematic Review and Meta-Analysis.

Authors:  Chan Hee Kim; Doo Yong Chung; Koon Ho Rha; Joo Yong Lee; Seon Heui Lee
Journal:  Medicina (Kaunas)       Date:  2020-12-30       Impact factor: 2.430

6.  Is retrograde intrarenal surgery the game changer in the management of upper tract calculi? A single-center single-surgeon experience of 131 cases.

Authors:  Kandarp Priyakant Parikh; Ravi Jineshkumar Jain; Aditya Parikh Kandarp
Journal:  Urol Ann       Date:  2018 Jan-Mar

Review 7.  Real-time simultaneous endoscopic combined intrarenal surgery with intermediate-supine position: Washout mechanism and transport technique.

Authors:  Hae Do Jung; Jong Chan Kim; Hyun Kyu Ahn; Joon Ho Kwon; Kichang Han; Woong Kyu Han; Man-Deuk Kim; Joo Yong Lee
Journal:  Investig Clin Urol       Date:  2018-07-16

8.  Efficacy and safety of fURS in stones larger than 20 mm: is it still the threshold?

Authors:  Mehmet Ali Karagöz; Ismet Bilger Erihan; Ömer Gökhan Doluoğlu; Çağlar Uğurlu; Murat Bağcıoğlu; Mehmet Uslu; Kemal Sarıca
Journal:  Cent European J Urol       Date:  2020-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.